Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2658 | 2182 | 34.5 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
218 | 3 | OSTEOSARCOMA//SARCOMA//CHORDOMA | 50416 |
1090 | 2 | CHORDOMA//OSTEOSARCOMA//CHONDROSARCOMA | 9848 |
2658 | 1 | OSTEOSARCOMA//MUSCULOSKELETAL ONCOL//METASTATIC OSTEOSARCOMA | 2182 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OSTEOSARCOMA | authKW | 3296999 | 47% | 23% | 1021 |
2 | MUSCULOSKELETAL ONCOL | address | 199115 | 3% | 23% | 62 |
3 | METASTATIC OSTEOSARCOMA | authKW | 174356 | 1% | 69% | 18 |
4 | SEZ CHEMIOTER IA | address | 169288 | 1% | 55% | 22 |
5 | PEDIATRIC OSTEOSARCOMA | authKW | 99940 | 0% | 71% | 10 |
6 | SEZIONE CHEMIOTER IA | address | 85702 | 0% | 88% | 7 |
7 | MULTIFOCAL OSTEOSARCOMA | authKW | 83955 | 0% | 100% | 6 |
8 | MIFAMURTIDE | authKW | 52734 | 0% | 54% | 7 |
9 | RIC ONCOL | address | 51889 | 1% | 23% | 16 |
10 | CLIN COOPERAT GRP OSTEOSARCOMA | address | 47213 | 0% | 38% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 28053 | 58% | 0% | 1269 |
2 | Orthopedics | 3642 | 11% | 0% | 250 |
3 | Pediatrics | 1176 | 9% | 0% | 194 |
4 | Surgery | 703 | 12% | 0% | 254 |
5 | Pathology | 534 | 5% | 0% | 111 |
6 | Hematology | 502 | 5% | 0% | 118 |
7 | Radiology, Nuclear Medicine & Medical Imaging | 435 | 7% | 0% | 146 |
8 | Medicine, Research & Experimental | 245 | 5% | 0% | 112 |
9 | Genetics & Heredity | 207 | 5% | 0% | 120 |
10 | Cell Biology | 82 | 5% | 0% | 116 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MUSCULOSKELETAL ONCOL | 199115 | 3% | 23% | 62 |
2 | SEZ CHEMIOTER IA | 169288 | 1% | 55% | 22 |
3 | SEZIONE CHEMIOTER IA | 85702 | 0% | 88% | 7 |
4 | RIC ONCOL | 51889 | 1% | 23% | 16 |
5 | CLIN COOPERAT GRP OSTEOSARCOMA | 47213 | 0% | 38% | 9 |
6 | COOPERAT OSTEOSARKOMSTUDIENGRP | 41977 | 0% | 100% | 3 |
7 | SHANGHAI MICROSURG EXTREM | 41977 | 0% | 100% | 3 |
8 | ORTHOPED | 40406 | 11% | 1% | 246 |
9 | BONE TUMOR REFERENCE | 37767 | 0% | 30% | 9 |
10 | CARDIOONCOL | 31481 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEDIATRIC BLOOD & CANCER | 8626 | 2% | 1% | 53 |
2 | JOURNAL OF BONE ONCOLOGY | 6220 | 0% | 6% | 7 |
3 | CANCER | 6016 | 5% | 0% | 110 |
4 | CLINICAL ORTHOPAEDICS AND RELATED RESEARCH | 5208 | 4% | 0% | 78 |
5 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 4151 | 2% | 1% | 33 |
6 | JOURNAL OF CLINICAL ONCOLOGY | 3897 | 3% | 0% | 68 |
7 | TUMOR BIOLOGY | 3764 | 2% | 1% | 41 |
8 | GENES CHROMOSOMES & CANCER | 2718 | 1% | 1% | 25 |
9 | MEDICAL ONCOLOGY | 2217 | 1% | 1% | 23 |
10 | ANNALS OF ONCOLOGY | 2147 | 2% | 0% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OSTEOSARCOMA | 3296999 | 47% | 23% | 1021 | Search OSTEOSARCOMA | Search OSTEOSARCOMA |
2 | METASTATIC OSTEOSARCOMA | 174356 | 1% | 69% | 18 | Search METASTATIC+OSTEOSARCOMA | Search METASTATIC+OSTEOSARCOMA |
3 | PEDIATRIC OSTEOSARCOMA | 99940 | 0% | 71% | 10 | Search PEDIATRIC+OSTEOSARCOMA | Search PEDIATRIC+OSTEOSARCOMA |
4 | MULTIFOCAL OSTEOSARCOMA | 83955 | 0% | 100% | 6 | Search MULTIFOCAL+OSTEOSARCOMA | Search MULTIFOCAL+OSTEOSARCOMA |
5 | MIFAMURTIDE | 52734 | 0% | 54% | 7 | Search MIFAMURTIDE | Search MIFAMURTIDE |
6 | NONMETASTATIC OSTEOSARCOMA | 44774 | 0% | 80% | 4 | Search NONMETASTATIC+OSTEOSARCOMA | Search NONMETASTATIC+OSTEOSARCOMA |
7 | HIGH GRADE OSTEOSARCOMA | 43723 | 0% | 63% | 5 | Search HIGH+GRADE+OSTEOSARCOMA | Search HIGH+GRADE+OSTEOSARCOMA |
8 | BONE SARCOMA | 42048 | 1% | 15% | 20 | Search BONE+SARCOMA | Search BONE+SARCOMA |
9 | DOXORUBICIN BINDING | 41977 | 0% | 100% | 3 | Search DOXORUBICIN+BINDING | Search DOXORUBICIN+BINDING |
10 | OSTEOGENIC SARCOMA | 36525 | 1% | 16% | 16 | Search OSTEOGENIC+SARCOMA | Search OSTEOGENIC+SARCOMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LUETKE, A , MEYERS, PA , LEWIS, I , JUERGENS, H , (2014) OSTEOSARCOMA TREATMENT - WHERE DO WE STAND? A STATE OF THE ART REVIEW.CANCER TREATMENT REVIEWS. VOL. 40. ISSUE 4. P. 523 -532 | 67 | 88% | 159 |
2 | FERGUSON, WS , GOORIN, AM , (2001) CURRENT TREATMENT OF OSTEOSARCOMA.CANCER INVESTIGATION. VOL. 19. ISSUE 3. P. 292 -315 | 146 | 63% | 174 |
3 | ANNINGA, JK , GELDERBLOM, H , FIOCCO, M , KROEP, JR , TAMINIAU, AHM , HOGENDOORN, PCW , EGELER, RM , (2011) CHEMOTHERAPEUTIC ADJUVANT TREATMENT FOR OSTEOSARCOMA: WHERE DO WE STAND?.EUROPEAN JOURNAL OF CANCER. VOL. 47. ISSUE 16. P. 2431 -2445 | 71 | 75% | 100 |
4 | VIJAYAMURUGAN, N , BAKHSHI, S , (2014) REVIEW OF MANAGEMENT ISSUES IN RELAPSED OSTEOSARCOMA.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 14. ISSUE 2. P. 151 -161 | 73 | 82% | 4 |
5 | ANDERSON, ME , (2016) UPDATE ON SURVIVAL IN OSTEOSARCOMA.ORTHOPEDIC CLINICS OF NORTH AMERICA. VOL. 47. ISSUE 1. P. 283 -+ | 39 | 83% | 12 |
6 | JEON, DG , SONG, WS , (2010) HOW CAN SURVIVAL BE IMPROVED IN LOCALIZED OSTEOSARCOMA?.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 10. ISSUE 8. P. 1313-1325 | 82 | 73% | 7 |
7 | MEAZZA, C , SCANAGATTA, P , (2016) METASTATIC OSTEOSARCOMA: A CHALLENGING MULTIDISCIPLINARY TREATMENT.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 16. ISSUE 5. P. 543 -556 | 72 | 70% | 0 |
8 | BAKHSHI, S , RADHAKRISHNAN, V , (2010) PROGNOSTIC MARKERS IN OSTEOSARCOMA.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 10. ISSUE 2. P. 271 -287 | 68 | 67% | 24 |
9 | HATTINGER, CM , FANELLI, M , TAVANTI, E , VELLA, S , FERRARI, S , PICCI, P , SERRA, M , (2015) ADVANCES IN EMERGING DRUGS FOR OSTEOSARCOMA.EXPERT OPINION ON EMERGING DRUGS. VOL. 20. ISSUE 3. P. 495 -514 | 63 | 56% | 8 |
10 | FERRARI, S , SERRA, M , (2015) AN UPDATE ON CHEMOTHERAPY FOR OSTEOSARCOMA.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 16. ISSUE 18. P. 2727 -2736 | 43 | 84% | 6 |
Classes with closest relation at Level 1 |